Open Access

Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms

  • Hadjer Saidi1,
  • Sonia Adi-Bessalem1,
  • Djelila Hammoudi-Triki1 and
  • Fatima Laraba-Djebari1Email author
Journal of Venomous Animals and Toxins including Tropical Diseases201319:8

https://doi.org/10.1186/1678-9199-19-8

Received: 2 October 2012

Accepted: 20 November 2012

Published: 9 April 2013

Abstract

Background

Previous works had shown that scorpion venom induced neurotransmitter elevation and an inflammatory response associated with various anatomo-pathological modifications. The most dangerous scorpions species in Algeria responsible for these effects are Androctonus australis hector (Aah) and Androctonus amoreuxi (Aam).

Results

Comparison of the physiopathological effects induced by the two venoms showed differences in the kinetic of cytokine release and in lung injury.

The lung edema was only observed in response to Aah venom and it was correlated with cell infiltration. In order to better understand the involved mechanism in inflammatory response, we used two antagonists, atropine (non-selective muscarinic antagonist) and propranolol (β adrenergic antagonist), which lead to a decrease of cell infiltration but has no effect on edema forming.

Conclusion

These results suggest another pathway in the development of lung injury following envenomation with Aam or Aah venom.

Keywords

Scorpion venomsCytokinesLung inflammationAcetylcholineAtropinePropranolol

Background

Scorpion envenomation is a serious problem common to many countries. In Algeria the most dangerous scorpion species are Androctonus australis hector (Aah), Buthus occitanus tunetanus (Bot) and Androctonus amoreuxi (Aam). Scorpion venoms are known to stimulate the autonomic nervous system simultaneously with release of tissue and medulla catecholamine [14]; induce an inflammatory response characterized by increase of cytokines, prostaglandines, leukotrienes, and platelet activated factor (PAF) in sera associated with inflammatory cell infiltration in tissues, especially lung [58].

Lung edema is the main cause of death after scorpion stings [911]. Its pathogenesis could be due to a non-cardiogenic effect following activation of inflammatory cascade and/or due to a cardiogenic effect [6, 1215]. Catecholamine may induce pulmonary edema via both hemodynamic and inflammatory mechanisms, by augmenting the IL-6 level [16]. The autonomic effects on inflammation are not restricted to catecholamine since the use of muscarinic antagonists may prevent some of the underlying cellular inflammatory responses in the lungs in addition to reducing smooth muscle contraction and mucus secretion [17, 18]. Furthermore, the muscarinic antagonist, atropine significantly reduces neutrophil influx in lungs [19]. These polynuclear cells migrate into the lungs as a direct response to various proinflammatory stimuli and might contribute to many disorders such as acute respiratory distress syndrome (ARDS) [20, 21].The present study is designed to investigate the mechanism by which venoms of two scorpions, found in Algeria and belonging to the same genus Androctonus, lead to lung inflammation by using atropine and propranolol.

Methods

Biological materials

Venoms

Lyophilized venoms of Androctonus australis hector and Androctonus amoreuxi, with respective LD50 of 0.85 and 0.75 mg/kg, were obtained from the Pasteur Institute of Algeria.

Animals

Male NMRI mice (20 ± 2 g), provided by the Pasteur Institute of Algeria, were used for all experiments. The animals were kept under controlled environment and received food and water ad libitum. The experimental protocol was in accord with the guidelines for the care of laboratory animals published by the European Union.

Non-biological materials

Chemical products and reagents used in these experiments were purchased from Sigma (USA), Merck (Germany) or Panreac (Spain). Pharmaceutical products were acquired from other firms, the atropine sulfate from Renaudin (France) and the propranolol from AstraZeneca (France).

Effect of Androctonus amoreuxi venom on cytokine levels

Groups of mice were injected by subcutaneous (s.c.) route with a sublethal dose of Aam venom dissolved in saline solution; control mice received 0.2 mL of saline solution alone. Mice were bled at several moments and sera were separated and stored at -20°C.

Cytokines were measured by specific sandwich ELISA, using cytokine Amersham kits for IL-1β, IL-6, and IL-10 according to the manufacturer’s instructions. Binding of biotinylated monoclonal antibodies was detected using streptavidin-biotinylated horseradish peroxidase complex and 3, 3’, 5, 5’ tetramethylbenzidine (TMB). Samples were quantified by comparison with standard curves of recombinant mouse cytokines. The lower limits of detection were 3 pg/mL (IL-1β), 7 pg/mL (IL-6) and 12 pg/mL (IL-10).

Effects of venoms on lung tissue

The effects of a sublethal dose of the two venoms, Aam and Aah, in the presence or absence of antagonists on lungs were evaluated by: estimation of myeloperoxydase activity as a marker of neutrophilia and histological study. Atropine sulfate (1 mg/kg) was injected intraperitoneally (i.p. route) 30 minutes before venoms and propranolol (0.1 mg/kg) was injected by the same route at two moments, 15 minutes before and 15 minutes after venom administration.

Myeloperoxydase activity

Three hours after envenomation by Aam or Aah venom, the removed lungs were homogenized in Tris–HCl buffer 50 mM, pH 6.6, then centrifuged at 6000 rpm for 30 minutes. The first supernatant (S1) was conserved at 4°C and the second supernatant (S2) was recovered after three freeze-thaw cycles of the pellet followed by its centrifugation at the above mentioned buffer conditions, rate and duration. One hundred microliters of S1 and 100 μL of S2 were added to 300 μL of chromogene substrate (0.167 mM O-dianisidine prepared in Tris–HCl 50 mM; pH 6.6 and H2O2 8.8 mM) and the resulting mixture was read at the absorbance of 460 nm after one minute of incubation at room temperature.

Histological study

Lungs were fixed in 4% formaldehyde for 48 hours at room temperature, dehydrated in ethanol, cleared in xylen and embedded in paraffin. Histological sections (3-μm thick) were cut and stained with hematoxylin-eosin (H&E) for microscopic examination (Motic Digital Microscope PAL system).

Statistical analysis

The obtained data were expressed as mean ± SD and analyzed by, ANOVA with the significance level defined as p < 0.05.

Results

Effect of Aam and Aah venoms on cytokine release

In the present study, the sera of mice envenomed by Aam displayed an increase of proinflammatory cytokines (IL-1β and IL-6). The comparison between Aam and Aah showed that the IL-1β level was more important in response to Aah venom (60 ± 12 pg/mL) versus (22.85 ± 2.15 pg/mL) (Figure 1 – A), while the maximum release of IL-6 was detected 60 minutes after Aam injection (237.66 ± 20.5 pg/mL), 180 minutes after administration of Aah venom (56 ± 2.89 pg/mL) followed by a significant elevation at 1440 minutes only in mice envenomed with Aam venom (Figure 1 – B).
Figure 1

Kinetic of cytokines release in sera following Aam or Aah injection. (A) IL-1β, (B) IL-6, (C) IL-10 *p < 0.05, **p < 0.01, ***p < 0.001, NS: not significant, compared to control.

In addition to the production of proinflammatory cytokines, the Aam and Aah venoms induced a significant release of an anti-inflammatory cytokine (IL-10). A biphasic profile was observed in response to Aam, the first peak measured at 60 minutes (162 ± 16.35 pg/mL), the second one at 360 minutes (104 ± 10.22 pg/mL), whereas only one peak was observed at 60 minutes (562.5 ± 59.3 pg/mL) in response to Aah venom (Figure 1 – C). Elevation of this cytokine was also reported in mice envenomed with Centruroides noxius venom [22].

Myeloperoxydase activity

Rapid accumulation in lungs of neutrophils in response to any proinflammatory stimulus is one of the first recognizable events in the pathogenesis of many pulmonary diseases [23, 24]. Neutrophil recruitment into lungs was evaluated by myeloperoxydase activity in this study, the two venoms induced neutrophil infiltration with more pronounced effect when Aam venom was injected (0.902 ± 0.071) versus (0.474 ± 0.033) (Figure 2).
Figure 2

Effect of Androctonus amoreuxi and Androctonus australis hector venoms on myeloperoxydase activity in the presence or absence of atropine (At) and propranolol (Pr). *p < 0.05, **p < 0.01, **p < 0.001.

The increase of pulmonary MPO activity was also observed in mice envenomed with Aah and Tityus serrulatus venoms [25, 26].

Antagonists’ effectiveness in reducing neutrophil influx depended on the venom injected; in comparison to propranolol, atropine significantly prevented neutrophil recruitment in the presence of Aam venom and showed the same effect in response to Aah venom (Figure 2).

Lung histology

Lung tissue micrographs from mice envenomed by Aam or Aah showed hemorrhage, thickening of the inter-alveolar septa with a high accumulation of inflammatory cells (Figure 3 – A1, A’1, B1, B’1). These effects are more pronounced in response to Aah venom which showed, in addition to these anatomopathologic modifications, some edematous area (Figure 3 – B1).
Figure 3

Effects of Androctonus amoreuxi and Androctonus australis hector venoms on pulmonary parenchyma. (A1 and B1) Magnification of 400×, (A’1 and B’1) magnification of 100×, in the presence of atropine (A2, B2) or propranolol (A3, B3 and B’3), (C) control injected with saline. A: alveolus, E: edema, H: hemorrhage, IC: inflammatory cells, Hematoxylin-Eosin.

Administration of atropine, a non-selective muscarinic antagonist or propranolol, a β adrenergic antagonist prior to the venom administration showed that atropine is more effective than propranolol at preventing inflammatory cell influx (Figure 3 – A2, B2, A3, B3). The lung edema observed in response to Aah venom was augmented in mice pretreated by the two antagonists (Figure 3 – B2, B’3).

Discussion

Several studies emphasized the relevance of proinflammatory cytokines in the pathophysiological manifestations of scorpion envenomation and showed their correlation with severity [2730].

The results of the present study showed that Aam and Aah venoms induced the release of proinflammatory cytokines IL-1β and IL-6. This finding is in agreement with previous studies that indicate an increase in circulating inflammatory cytokines after envenoming with several scorpion venoms such as Tityus serrulatus, Tityus discripans, Centruroides noxius, Leiurus quinquestriatus quinquestriatus and Buthus occitanus[7, 22, 2729, 3133].

Cytokine levels differed significantly, with Aam venom inducing an earlier increase of IL-6 compared to Aah venom. This result can be explained by the high early level of anti-inflammatory cytokine (IL-10) in response to Aah venom. Indeed IL10 is known to play a modulatory role, down-regulating multiple aspects of immune and inflammatory responses through the regulation of the proinflammatory cytokines (IL-1β, IL-6 and TNF-α) [34, 35].

The discrepancy in neutrophil influx observed in response to the Aam and Aah venoms may be attributable to their different levels of IL-6 release. This result is supported by previous data which showed that proinflammatory cytokines are responsible for leukocyte recruitment by inducing the elevation of chemokines and expression of adhesion molecules such as ICAM-1 and VLA-4 in endothelial cells [36]. The increase of chemokines might result in the binding of acetylcholine to muscarinic receptors [37, 38].

Administration of atropine or propranolol prior to envenomation reduced neutrophilia in the lungs. This result suggests an inflammatory effect of both muscarinic and β adrenergic stimulation, as reflected in the ability of each antagonist to reduce neutrophil recruitment; which depends on the venom injected. Atropine was more effective than propranolol in preventing neutrophil influx following Aam injection. This observation is probably related to the amount of neurotransmitter released with a predominance of cholinergic stimulation in the presence of Aam venom.

This cholinergic predominance could explain in part the absence of an edematous area in lungs of mice envenomed by Aam venom, since the binding of Ach to muscarinic receptors decreases cardiac contraction, whereas excessive catecholamine release might give rise to left ventricular dysfunction that, in turn, may form lung edema [14, 15, 3943]. Lung edema observed in pheochromocytoma patients or induced experimentally by catecholamine was prevented by pretreatment with α adrenergic blockers [16, 4447]. However our study showed that pulmonary edema subsequent to Aah venom was not reduced by propranolol or atropine. A similar effect was observed following propranolol administration in patients with pheochromcytoma [48]. Ismail [49] explained the effect of atropine by the accentuation of arterial hypertension.

The present comparison of lung micrographs between Aam and Aah also showed that an edematous area is observed only in response to Aah venom which induced a more important leukocyte infiltration in alveolar walls. These data are supported by previous studies which reported that edema formation in scorpion envenomation is attributable in part to activation of the inflammatory cascade and the release of lipid-derived mediators of inflammation, including PAF, leukotrienes and prostaglandins secreted after activation of mast cells by neuropeptides such as substance P [6, 12, 13].

The influx of inflammatory cells into pulmonary parenchyma was reduced by atropine and propranolol. These results are similar to other studies which ascribed inflammatory effects to β adrenergic stimulation, thus indicating that most inflammatory cells express functional muscarinic receptors and showed that atropine administration inhibits the migration of leucocytes towards the site of inflammation, and blocked increase of leucocytes in splenic venous blood in response to carbacholine [5056].

Conclusion

In conclusion, the comparative study of inflammatory response induced by Aam and Aah venoms showed not only the role of the neuroendocrine-immune axis in the development of lung inflammation with more important parasympathetic involvement in envenomed mice by Aam, but also that the role of atropine or propranolol in reducing inflammatory cells influx is independent of their effect on lung edema formation. The variability of venoms must be elucidated before an efficient treatment can be developed.

Declarations

Acknowledgements

Authors are highly thankful to ATSS (ex ANDRS) and PNR for financial assistance; acknowledge professor Ziani-Mameri Saadia (anatomopathologist in Beni Messous’ hospital) and Bekkari Nadjia for their contribution.

Authors’ Affiliations

(1)
USTHB, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumedienne

References

  1. Patterson RA: Physiological action of scorpion venom. AmJTrop Med Hyg 1960, 9(4):410–414.Google Scholar
  2. Ismail M, Osman OH, Ibrahim SA, el-Asmar MF: Cardiovascular and respiratory responses to the venom from the scorpion Leiurus quinquestriatus. East Afr Med J 1972, 49(4):275–281.Google Scholar
  3. Ismail M, Osman OH, el-Asmar MF: Pharmacological studies of the venom from the scorpion Buthus minax (L. Koch). Toxicon 1973, 11(1):15–20. 10.1016/0041-0101(73)90146-3PubMedGoogle Scholar
  4. Ismail M, Osman OH, Gumaa KA, Karrar MA: Some pharmacological studies with scorpion (Pandinus exitialis ) venom. Toxicon 1973, 12(1):75–82.Google Scholar
  5. Freire-Maia L, de Matos IM: Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary oedema induced by Tityus serrulatus scorpion venom in the rat. Toxicon 1993, 31(9):1207–1210. 10.1016/0041-0101(93)90137-8PubMedGoogle Scholar
  6. De-Matos IM, Talvani A, Freire-Maia L, Teixeira MM: Evidence for the role of mast cells in the lung edema induced by Tityus serrulatus venom in rats. Toxicon 2001, 39(6):861–867.Google Scholar
  7. Fukuhara YD, Reis ML, Dellalibera-Joviliano R, Cunha FQ, Donadi EA: Increased plasma levels of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 2003, 41(1):49–55. 10.1016/S0041-0101(02)00208-8PubMedGoogle Scholar
  8. Adi-Bessalem S, Hammoudi-Triki D, Laraba-Djebari F: Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response. Exp Toxicol Pathol 2008, 60(4–5):373–380.PubMedGoogle Scholar
  9. Campos JA, Silva OA, Lopes M, Freire-Maia L: Signs symptoms and treatment of severe scorpion sting in children. Toxicon 1979, 17(1):19.Google Scholar
  10. Goyffon M, Vachon M, Broglio N: Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon 1982, 20(1):337–344. 10.1016/0041-0101(82)90240-9PubMedGoogle Scholar
  11. Hering ES, Jurca M, Vichi FL, Azevedo-Marques MM, Cupo P: ‘Reversible cardiomyopathy’ in patients with severe scorpion envenoming by Tityus serrulatus: evolution of enzymatic, electrocardiographic and echocardiographic alterations. Ann Trop Paediatr 1993, 13(2):173–182.PubMedGoogle Scholar
  12. de Matos IM, Rocha OA, Leite R, Freire-Maia L: Lung edema induced by Tityus serrulatus scorpion venom in the rat. Comp Biochem Physiol 1997, 118(2):143–148.Google Scholar
  13. Matos IM, Souza DG, Seabra DG, Freire-Maia L, Teixeira MM: Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats. Eur J Pharmacol 1999, 376(3):293–300. 10.1016/S0014-2999(99)00382-9PubMedGoogle Scholar
  14. Gueron M, Margulis G, Sofer S: Echocardiographic and radionuclide angiographic observations following scorpion envenomation by Leiurus quinquestriatus. Toxicon 1990, 28(9):1005–1009. 10.1016/0041-0101(90)90138-WPubMedGoogle Scholar
  15. de Mazzei Dàvila CA, Dàvila DF, Donis JH, de Bellabarba GA, Villareal V, Barboza JS: Sympathetic nervous system activation, antivenin administration and cardiovascular manifestation of scorpion envenomation. Toxicon 2002, 40(9):1339–1346. 10.1016/S0041-0101(02)00145-9Google Scholar
  16. Rassler B, Reibig C, Briest W, Tannapfel A, Zimmer HG: Catecholamine-induced pulmonary edema and pleural effusion in rats alpha- and beta- adrenergic effects. Respir Physiol Neurobiol 2003, 135(1):25–37. 10.1016/S1569-9048(03)00062-4PubMedGoogle Scholar
  17. Profita M, Giorgi RD, Sala A, Bonanno A, Riccobono L, Mirabella F, et al.: Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60(11):1361–1369. 10.1111/j.1398-9995.2005.00892.xPubMedGoogle Scholar
  18. Undem BJ, Kollarik M: The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(4):355–360. 10.1513/pats.200504-033SRPubMed CentralPubMedGoogle Scholar
  19. McQueen DS, Donaldson K, Bond SM, McNeilly JD, Newman S, Bartona NJ, et al.: Bilateral vagotomy or atropine pre treatment reduces experimental diesel-soot induced lung inflammation. Toxicol Appl Pharmacol 2007, 219(1):62–71. 10.1016/j.taap.2006.11.034PubMedGoogle Scholar
  20. Rolanld H, Ingram JR: Syndrome de détresse respiratoire aigue de l’adulte. In Harrison- Principes de médicine interne. Edited by: Wilson JD, Braunwalf E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK. Medicine Sciences Flammarion, Paris; 1992:1122–1125.Google Scholar
  21. Wagner JG, Roth RA: Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000, 52(3):349–374.PubMedGoogle Scholar
  22. Petricevich VL: Balance between pro- and anti-inflammatory cytokines in mice treated with Centruroides noxius scorpion venom. Mediators Inflamm 2006, 2006(6):1–11.Google Scholar
  23. Worthen GS, Nick JA: Pulmonary diseases and disorders. Edited by: Fishman AP. Mac Graw-Hill, New York; 1998:325.Google Scholar
  24. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Swatt BT, et al.: Role of p38 mitogen activated protein kinase in murin model of pulmonary inflammation. J Immunol 2000, 164(4):2151–2159.PubMedGoogle Scholar
  25. Coelho FM, Pessini AC, Coelho AM, Pinho VS, Souza DG, Arantes EC, et al.: Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon 2007, 50(3):420–427. 10.1016/j.toxicon.2007.04.009PubMedGoogle Scholar
  26. Adi-Bessalem S, Mendil A, Hammoudi-Triki D, Laraba-Djebari F: Lung immunoreactivity and airway inflammation: Their assessment after scorpion envenomation. Inflammation 2012, 35(2):501–508. 10.1007/s10753-011-9338-0PubMedGoogle Scholar
  27. Meki AR, Mohey El-Dean ZM: Serum interleukin-1β, interleukin-6, nitric oxide and α1 antitrypsin in scorpion envenomed children. Toxicon 1998, 26(12):1851–1859.Google Scholar
  28. Hammoudi-Triki D, Ferquel E, Robbe-Vincent A, Bon C, Choumet V, et al.: Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: effect of immuno-therapy. Trans R Soc Trop Med Hyg 2004, 98(4):240–250. 10.1016/S0035-9203(03)00062-2PubMedGoogle Scholar
  29. Abdel Haleem AA, Meki AR, Noaman HA, Mohamed ZT: Serum levels of IL6 and its soluble receptor, TNF-α and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome. Toxicon 2006, 47(4):437–444. 10.1016/j.toxicon.2005.12.008PubMedGoogle Scholar
  30. Sofer S, Gueron M, White RM, Lifshitz M, Apte RN: Interleukin-6 release following scorpion sting in children. Toxicon 1996, 34(3):389–392. 10.1016/0041-0101(95)00136-0PubMedGoogle Scholar
  31. D’Suze G, Moncada S, González C, Sevcik C, Aguilar V, Alagón A: Relationship between plasmatic levels of various cytokines, tumor necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting. Toxicon 2003, 41(3):367–375. 10.1016/S0041-0101(02)00331-8PubMedGoogle Scholar
  32. Andrade MV, Lisboa FA, Portugal AL, Arantes RM, Cunha-Melo JR: Scorpion venom increases mRNA expression of lung cytokines. Comp Biochem Physiol A Mol Integr Physiol 2007, 146(4):581–587. 10.1016/j.cbpa.2006.01.031PubMedGoogle Scholar
  33. Abdoon N, Fatani A: Correlation between blood pressure, cytokines and nitric oxide in conscious rabbits injected with Leiurus quinquestriatus quinquistratus scorpion venom. Toxicon 2009, 54(4):471–480. 10.1016/j.toxicon.2009.05.009PubMedGoogle Scholar
  34. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by IL-10. J Exp Med 1991, 174(6):1549–1555. 10.1084/jem.174.6.1549PubMedGoogle Scholar
  35. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1992, 147(11):3815–3822.Google Scholar
  36. Voronov E, Apte RN, Sofer S: The systemic inflammatory response syndrome related to the release of cytokines following severe envenomation. J Venom Anim Toxins 1999, 5(1):19–23.Google Scholar
  37. Koyama S, Rennard SI, Robbins RA: Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1992, 262(4 Pt 1):L466-L471.PubMedGoogle Scholar
  38. Profita M, Bonanno A, Siena L, Ferraro M, Montalbano AM, Pompeo F, et al.: Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. Eur J Pharmacol 2008, 582(1–3):145–153.PubMedGoogle Scholar
  39. Parthasarathy PR, Venkaiah B: Histopathological study on the effect of venom from the scorpion Heterometrus fulvipes. Ind J Path Microbial 1986, 29(2):155–158.Google Scholar
  40. Gueron M, Ovsyscher I: What is the treatment for the cardiovascular manifestations of scorpion envenomation? Toxicon 1987, 25: 121–124. 10.1016/0041-0101(87)90170-XPubMedGoogle Scholar
  41. Gueron M, Ilia R, Sofer S: The cardiovascular system after scorpion envenomation a review. Clin Toxicol 1992, 30(2):245–258. 10.3109/15563659209038636Google Scholar
  42. Bucaretchi F, Baracat EC, Nogueira RJ, Chaves A, Zambrone FA, Fonseca MR, et al.: Comparative study of severe scorpion envenomation in children caused by Tityus bahiensis and Tityus serrulatus. Rev Inst Med Trop Sao Paulo 1995, 37(4):331–336. 10.1590/S0036-46651995000400008PubMedGoogle Scholar
  43. Gueron M, Ilia R: Non- cardiogenic pulmonary oedema after scorpion envenomation: a true antity? Toxicon 1996, 34(4):393–395. 10.1016/0041-0101(95)00147-6PubMedGoogle Scholar
  44. Ferrari W, Baggio G, Guarini S: Studies on epinephrine-induced lung edema in the rat. I. Selective a1-adrenoceptor involvement. Arch Int Pharmacodyn Ther 1986, 281(1):89–99.PubMedGoogle Scholar
  45. Tauzin-Fin P, Hilbert G, Krol-Houdek M, Gosse P, Maurette P: Mydriasis and acute pulmonary oedema complicating laparoscopic removal of phaeochromocytoma. Anaesth Intensive Care 1999, 27(6):646–649.PubMedGoogle Scholar
  46. Van Iperen CE, Giezen J, Kramer WL, Lips CJ, Bartelink AK: Acute dyspnoea resulting from pulmonary oedema as the first sign of a phaeochromocytoma. Respiration 2001, 68(3):323–326. 10.1159/000050519PubMedGoogle Scholar
  47. Rassler B, Barth W, Zimmer HG: Transient pleural effusion in norepinephrine-stimulated rats. Basic Res Cardiol 2001, 96(5):265–273.Google Scholar
  48. Sloand EM, Thompson BT: Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med 1984, 144(1):173–174. 10.1001/archinte.1984.00350130201036PubMedGoogle Scholar
  49. Ismail M: The scorpion envenoming syndrome. Toxicon 1995, 33(7):825–858. 10.1016/0041-0101(95)00005-7PubMedGoogle Scholar
  50. Sandberg G: Leucocyte mobilization from the guinea pig spleen by muscarinic cholinergic stimulation. Experientia 1994, 50(1):40–43. 10.1007/BF01992047PubMedGoogle Scholar
  51. Chi DS, Qui M, Krishnaswamy G, Li C, Stone W: Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 2003, 8(2):127–132. 10.1016/S1089-8603(02)00148-9PubMedGoogle Scholar
  52. Gosens R, Zaagsma J, Grootte Bromhaar M, Nelemans A, Meurs H: Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur J Pharmacol 2004, 500(1–3):193–201.PubMedGoogle Scholar
  53. Gwilt CR, Donnelly LE, Rogers DF: The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 2007, 115(2):208–222. 10.1016/j.pharmthera.2007.05.007PubMedGoogle Scholar
  54. Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM: Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophage via PKA- and NF kappaB – independent mechanisms. Cell Signal 2007, 19(2):251–260. 10.1016/j.cellsig.2006.06.007PubMedGoogle Scholar
  55. Razani-Boroujerdi S, Behl M, Hahn FF, Pena-Phillipides JC, Sopori ML: Role of muscarinic receptors in the regulation of immune and inflammatory responses. J Neuroimmunol 2008, 194(1–2):83–88.PubMed CentralPubMedGoogle Scholar
  56. Wessler I, Kirkpatrick CJ: Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 2008, 154(8):1558–1571.PubMed CentralPubMedGoogle Scholar

Copyright

© Saidi et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.